Pioglitazona y su relación con el cáncer de vejiga. Revisión sistemática
Open Access
- 5 June 2024
- journal article
- Published by Revista Mexicana de Urologia based at Sociedad Mexicana de Urologia. Colegio de Profesionales AC. in Revista Mexicana de Urología
- Vol. 84 (2) , 1-17
Abstract
Description: bladder cancer is a public health problem since it is among the 10 most frequent cancers in men, it is related to multiple risk factors among which Pioglitazone stands out. Relevance: there is controversy in the results of the different studies regarding the true relationship between Pioglitazone and bladder cancer, since some support its relationship, while in others there is no association. Conclusions: more studies are still needed to definitively establish the true relationship since the current information is contradictory.Keywords
This publication has 17 references indexed in Scilit:
- Bladder cancer with pioglitazone: A case–control studyDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2022
- Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trialsScientific Reports, 2020
- Global Versus Indian Perspective of Pioglitazone-induced Adverse Drug Reactions Including Bladder Cancer: A Comparative Retrospective Pharmacovigilance AnalysisClinical Therapeutics, 2019
- A systematic review of observational studies of the association between pioglitazone use and bladder cancerDiabetic Medicine, 2018
- Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world dataClinical Epidemiology and Global Health, 2018
- Pioglitazone and bladder cancer risk: a systematic review and meta‐analysisCancer Medicine, 2018
- An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug’s effect on cardiovascular disease and non-alcoholic steatohepatitisDiabetes Research and Clinical Practice, 2018
- Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetesDiabetes, Obesity and Metabolism, 2017
- Pioglitazone and the Risk of Bladder Cancer: A Meta-AnalysisDiabetes Therapy, 2017
- Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysisCanadian Medical Association Journal, 2012